← Back to Clinical Trials
Recruiting NCT07237334

NCT07237334 A Prospective Cohort Study of Clinical and Process Outcomes of Older Adults That Transition Through the Geriatric Emergency Medicine Unit(GEM-U)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07237334
Status Recruiting
Phase
Sponsor University of Limerick
Condition Frailty
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2025-02-10
Primary Completion 2026-03-30

Eligibility & Interventions

Sex All sexes
Min Age 75 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2025-02-10 with a primary completion date of 2026-03-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will characterise the patients using the Geriatric Emergency Medicine Unit, a unit which provides specialist care for patients aged 75 years and older attending the emergency department. It will examine how this specialist care impacts their health in terms of a number of different outcomes, such as; function, quality of life and health care usage; for example admission to the acute hospital.

Eligibility Criteria

Inclusion Criteria: * Older adults aged ≥75 years * Manchester Triage System category 2-5 * Screen positive for risk of adverse outcomes after ED visit (≥ 2 on ISAR screening tool) * Presenting with a medical condition * Reviewed by the Older Persons Integrated Care Team Exclusion Criteria: * Patients presenting with a non-medical issue including major trauma or hip fracture * Patients presenting with acute stroke or transient ischaemic attack * Patients more appropriate to another alternative pathway e.g. deep vein thrombosis pathway, low risk chest pain pathway * Patients with acute coronary syndrome or unstable arrthymia * Patients requiring care in the resuscitation room * Patients with head injury (unless appropriate assessment and management has been fully completed by ED team) * Patients with possible spinal injury (unless appropriate assessment and management has been fully completed by ED/orthopaedic team) * Patients with low Glasgow Coma Scale * Other exclusions at the discretion of the Older Persons Integrated Care team depending on team capacity and expertise * Exclusion criteria as set out above, are in line with those set out in the UHL Operating Policy of the Older Persons Integrated Care Team.

Contact & Investigator

Central Contact

Ida M Carroll, MSc

✉ 09006791@studentmail.ul.ie

📞 0860638269

Principal Investigator

Ida Carroll

PRINCIPAL INVESTIGATOR

University of Limerick

Frequently Asked Questions

Who can join the NCT07237334 clinical trial?

This trial is open to participants of all sexes, aged 75 Years or older, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07237334 currently recruiting?

Yes, NCT07237334 is actively recruiting participants. Contact the research team at 09006791@studentmail.ul.ie for enrollment information.

Where is the NCT07237334 trial being conducted?

This trial is being conducted at Limerick, Ireland.

Who is sponsoring the NCT07237334 clinical trial?

NCT07237334 is sponsored by University of Limerick. The principal investigator is Ida Carroll at University of Limerick. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology